[1] LI D, YANG M, HU J, et al. Determination of penicillin g and its degradation products in a penicillin production wastewater treatment plant and the receiving river[J]. Water Research, 2008, 42(1/2): 307-317.
[2] HAN Z, LUAN X, FENG H, et al. Metagenomic insights into microorganisms and antibiotic resistance genes of waste antibiotic fermentation residues along production, storage and treatment processes[J]. Journal of Environmental Sciences, 2024, 136: 45-55. doi: 10.1016/j.jes.2022.10.035
[3] ZHANG Y, YANG M, LIU M, et al. Antibiotic pollution from Chinese drug manufacturing-antibiotic resistance[J]. Toxicology Letters, 2012, 211.
[4] LI D, QI R, YANG M, et al. Bacterial community characteristics under long-term antibiotic selection pressures[J]. Water Research, 2011, 45(18): 6063-6073. doi: 10.1016/j.watres.2011.09.002
[5] LIU M, DING R, ZHANG Y, et al. Abundance and distribution of Macrolide-Lincosamide-Streptogramin resistance genes in an anaerobic-aerobic system treating spiramycin production wastewater[J]. Water Research, 2014, 63: 33-41. doi: 10.1016/j.watres.2014.05.045
[6] European Union. European Waste Catalogue[DB/OL]. [2024-09-01]. https://naturalresourceswales.gov.uk/media/2001/european-waste-catalogue.pdf.
[7] 国家卫生健康委, 教育部, 科技部, 等. 遏制微生物耐药国家行动计划(2022-2025年)[DB/OL]. [2024-09-01]. http://www.nhc.gov.cn/yzygj/s7659/202210/2875ad7e2b2e46a2a672240ed9ee750f.shtml.
[8] World Health Organization. Technical brief on water, sanitation, hygiene and wastewater management to prevent infections and reduce the spread of antimicrobial resistance. Geneva: World health organization. [DB/OL]. [2024-09-01]. https://www.who.int/publications/i/item/9789240006416.
[9] World Health Organization. Guidance on wastewater and solid waste management for manufacturing of antibiotics[DB/OL]. [2024-09-02] https://iris.who.int/handle/10665/378471.
[10] LARSSON D G J, FLACH C F. Antibiotic resistance in the environment[J]. Nature Reviews Microbiology, 2021, 20(5): 257-269.
[11] BENGTSSON-PALME J, LARSSON D G J. Concentrations of antibiotics predicted to select for resistant bacteria: Proposed limits for environmental regulation[J]. Environment International, 2016, 86: 140-149. doi: 10.1016/j.envint.2015.10.015
[12] BRANDT K K, AMéZQUITA A, BACKHAUS T, et al. Ecotoxicological assessment of antibiotics: A call for improved consideration of microorganisms[J]. Environment International, 2015, 85: 189-205. doi: 10.1016/j.envint.2015.09.013
[13] LE P G, GUNNARSSON L, SNAPE J, et al. Integrating human and environmental health in antibiotic risk assessment: A critical analysis of protection goals, species sensitivity and antimicrobial resistance[J]. Environment International, 2017, 109: 155-169. doi: 10.1016/j.envint.2017.09.013
[14] YI Q Z, ZHANG Y, GAO Y X, et al. Anaerobic treatment of antibiotic production wastewater pretreated with enhanced hydrolysis: Simultaneous reduction of COD and ARGs[J]. Water Research, 2017, 110: 211-217. doi: 10.1016/j.watres.2016.12.020
[15] TANG L, FENG H D, LUAN X, et al. Occurrence, distribution, and behaviors of erythromycin A, production byproducts, transformation products, and resistance genes in a full-scale erythromycin a production wastewater treatment system[J]. Water Research, 2023, 245: 120640. doi: 10.1016/j.watres.2023.120640
[16] HE Y P, TIAN Z, LUAN X, et al. Recovery of biological wastewater treatment system inhibited by oxytetracycline: Rebound of functional bacterial population and the impact of adsorbed oxytetracycline on antibiotic resistance[J]. Chemical Engineering Journal, 2021, 418: 129364. doi: 10.1016/j.cej.2021.129364
[17] HAN Z M, FENG H D, WANG C, et al. Mitigating antibiotic resistance emissions in the pharmaceutical industry: Global governance and available techniques[J]. China CDC Weekly, 2023, 5(46): 1038-1044. doi: 10.46234/ccdcw2023.195
[18] HAN Z M, ZHANG Y, YANG M. Deterring the transmission of AMR in the environment: A Chinese perspective. Handbook on antimicrobial resistance: Current status, trends in detection and mitigation measures[DB/OL]. [2024-09-01]https://link.springer.com/referenceworkentry/10.1007/978-981-16-9723-4_52-1.
[19] ZHANG Y, WALSH T R, WANG Y, et al. Minimizing risks of antimicrobial resistance development in the environment from a public one health perspective[J]. China CDC Weekly, 2022, 4(49): 1105-1109. doi: 10.46234/ccdcw2022.224
[20] 生态环境部. 制药工业污染防治可行技术指南 [DB/OL]. [2024-09-01]. https://www.mee.gov.cn/xxgk2018/xxgk/xxgk06/202208/W020220830503913459046.pdf.
[21] Access to Medicine Foundation. Methods matter: What steps are companies taking to help curb AMR by manufacturing responsibly?[DB/OL]. [2024-09-01]. https://accesstomedicinefoundation.org/resource/what-are-pharmaceutical-companies-doing-to-limit-amr-risk-in-the-production-of-antibiotics.
[22] 中国医药企业管理协会. 中国制药工业EHS指南[DB/OL]. [2024-09-01]. https://www.cpema.org/uploadfile/2020/1123/20201123042101905.pdf.